SAM
LABU icon

SP Asset Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SP Asset Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$474K – 77
2018
Q2 		$474K Buy
+250
New +$440K 0.13% 52

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SP Asset Management's LABU Position: Q3 2018 in Review

SP Asset Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2018, closing a stake of 250 shares — an estimated $474K sold.

SP Asset Management first reported a position in LABU in Q2 2018 and held it in 1 quarter. The position peaked at $474K in Q2 2018. 18 funds tracked by Wall St. Rank hold LABU as of Q3 2018.

  • SP Asset Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2018 after selling out during the quarter.
  • SP Asset Management sold 250 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2018, an estimated $474K.
  • SP Asset Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2018 and held it in 1 quarter.
  • SP Asset Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $474K in Q2 2018.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2018.

Based on SP Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.